杂志概要
今天要介绍的期刊是 Cancer Letter
image.png
年文章数达到600+，命中率较高（Medsci的数据有些差异）
近几年的发文量，国人占比比较稳定，近年有升高趋势
image.png
影响因子
image.png
近几年影响因子基本稳定在****6****分多的水平，根据明年的预测影响因子，预计会达到 7.553****分
收稿内容方向
Cancer Letters是一本期刊，提供有关癌症研究广泛领域的简短文章的快速发表。该期刊着重于癌症的分子和细胞生物学，致癌基因，致癌作用，放射生物学，分子病理学，激素和癌症，病毒肿瘤学，癌症和转移生物学，分子细胞遗传学，流行病学；和实验性疗法。出版的主要标准是多学科读者的兴趣。论文应简短，但技术上应合理，并应有足够的实验细节加以证实。如果临床论文有助于理解疾病的基本机制，则将被接受。
从2001年1月开始在《****Cancer Letter****》上发表的论文将分为以下几个部分：
• 致癌和癌症预防，
• 实验治疗，
• 流行病学和分子流行病学，
• 分子和细胞生物学，
• 肿瘤生物学
敬请作者在向适当的编辑部提交稿件时选择希望其稿件出现的部分
战友经验
@e6de6d: 审稿速度:3|投稿命中率:50 经验分享：除夕那天（1月24号）投出去，过了近五天送外审，2月20号收到邮件，给了一个月的时间大修，没有补实验，主要是回答了审稿人和主编的问题，还包含了几个关键问题，不过总体来说很友好。3月17号修回，4月初接收，速度还是很快的！主编和审稿人都很有效率！
@ trlnd302 2020-03-27 发表:: 审稿时间：约1个月 我的文章去年11月中旬投稿，几天后天显示：with editor, under review, 大约一个月后，显示： require reviews completed, 持续了3天，然后变成：Decision in process, 此状态持续一周，然后又变成 With editor状态，2天后收到Internal Editor和Editor-in-Chief发来的邮件，Thank you for submitting your article to Cancer Letters, which I have read with interest. it is less clear that they provide the kind of conceptual advance that would elicit strong interest?among our readership. This decision only reflects the scope of Cancer Letters. When it seems that a paper falls short of meeting our standard publication criteria, we try to avoid unnecessary delays and return the manuscript without review. 我觉得很奇怪，明明已经送外审了啊！ 我估计Associate editor认可，所以送审了（开始主编应该没有细看），但是外审回来后到了主编手上，主编不喜欢，进而迟迟不下结论，并装出没有送审的样子（Decision in process 回到with editor状态，然后很快拒稿），连外审意见都不愿意发，浪费了我一个半月时间，实在恶心！最后还要我转到那个3分的杂志。
@ trlnd302 审稿速度:1 经验分享：我的文章去年11月中旬投稿，几天后天显示：with editor, under review, 大约一个月后，显示： require reviews completed, 持续了3天，然后变成：Decision in process, 此状态持续一周，然后又变成 With editor状态，2天后收到Internal Editor和Editor-in-Chief发来的邮件，Thank you for submitting your article to Cancer Letters, which I have read with interest. it is less clear that they provide the kind of conceptual advance that would elicit strong interest among our readership. This decision only reflects the scope of Cancer Letters. When it seems that a paper falls short of meeting our standard publication criteria, we try to avoid unnecessary delays and return the manuscript without review. 我觉得很奇怪，明明已经送外审了啊！ 我估计Associate editor认可，所以送审了（开始主编应该没有细看），但是外审回来后到了主编手上，主编不喜欢，进而迟迟不下结论，并装出没有送审的样子（Decision in process 回到with editor状态，然后很快拒稿），连外审意见都不愿意发，浪费了我一个半月时间，实在恶心！最后还要我转到那个3分的杂志。
@ yangx_53927823 2019-09-27 01:37:00 发表: Cancer Letters这个破杂志投了2篇，都是外审后拒掉，出的意见莫名其妙，非常不友好。转投其它6分杂志直接命中。这杂志最恶心的地方是，2次都是拒掉后马上推荐改投他家的3分烂刊，吃相太难看！！这杂志永远拉黑！！
Thank you for your interest and submission. Unfortunately, after careful consideration, I regret to inform you that I am unable to accept your manuscript, as noted above, for publication in "Cancer Letters". I have appended the comments of the reviewers in order for you to understand the basis for my final decision.
However, I do think that your manuscript has merit and may be suitable for another journal, Translational Oncology. I would like to suggest that you take advantage of the service that will transfer your manuscript files and details to that journal directly, without requiring you to resubmit everything yourself. Should you accept this transfer, you will have the opportunity to revise your paper, taking into account and benefitting from the reviews you have already received from "Cancer Letters". Such revision should take place after you initiate the transfer process but before you finalise the new submission, at which point you should include a cover letter detailing all changes.
[战友经验来源于Medsci期刊系统-版权归原作者所有]
战友经验供大家参考，总的来说，这本期刊影响因子稳定，年刊文量大，明年影响因子突破****7****分，白介素2同学建议，如果文章质量不错，值得一投。
网友评论